Cargando…

Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?

We report the case of a 64-year-old man followed up for two years as suffering from differentiated thyroid cancer (DTC). In the patient’s follow up, despite thyroglobulin level and I-131 whole body scan results being normal, metastases were identified at the 4th thoracic vertebra corpus by MR. Histo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulrezzak, Ummuhan, Tutus, Ahmet, Kula, Mustafa, Öztürk, Figen, Soyuer, Işın
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590961/
https://www.ncbi.nlm.nih.gov/pubmed/23487501
http://dx.doi.org/10.4274/Mirt.022866
_version_ 1782261953257799680
author Abdulrezzak, Ummuhan
Tutus, Ahmet
Kula, Mustafa
Öztürk, Figen
Soyuer, Işın
author_facet Abdulrezzak, Ummuhan
Tutus, Ahmet
Kula, Mustafa
Öztürk, Figen
Soyuer, Işın
author_sort Abdulrezzak, Ummuhan
collection PubMed
description We report the case of a 64-year-old man followed up for two years as suffering from differentiated thyroid cancer (DTC). In the patient’s follow up, despite thyroglobulin level and I-131 whole body scan results being normal, metastases were identified at the 4th thoracic vertebra corpus by MR. Histopathological findings were carcinoma metastases. F-18 FDG PET/CT showed increased metabolic activity in the right renal mass, bilaterally in the surrenal gland, multiple lymph nodes in the thoracic and abdominal para-aortic region and in multiple vertebral and pelvic bones. An excisional biopsy of the right renal mass was reported as renal cell carcinoma. Immunohistochemical staining performed retrospectively to the first thyroid preparation showed renal cell carcinoma metastases. Consequently, any patient who presents with a thyroid nodule can also be considered as possibly suffering from metastatic disease. F-18 FDG PET/CT can provide valuable information in finding the primary focus and metastases. Conflict of interest:None declared.
format Online
Article
Text
id pubmed-3590961
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-35909612013-03-13 Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That? Abdulrezzak, Ummuhan Tutus, Ahmet Kula, Mustafa Öztürk, Figen Soyuer, Işın Mol Imaging Radionucl Ther Case Reports We report the case of a 64-year-old man followed up for two years as suffering from differentiated thyroid cancer (DTC). In the patient’s follow up, despite thyroglobulin level and I-131 whole body scan results being normal, metastases were identified at the 4th thoracic vertebra corpus by MR. Histopathological findings were carcinoma metastases. F-18 FDG PET/CT showed increased metabolic activity in the right renal mass, bilaterally in the surrenal gland, multiple lymph nodes in the thoracic and abdominal para-aortic region and in multiple vertebral and pelvic bones. An excisional biopsy of the right renal mass was reported as renal cell carcinoma. Immunohistochemical staining performed retrospectively to the first thyroid preparation showed renal cell carcinoma metastases. Consequently, any patient who presents with a thyroid nodule can also be considered as possibly suffering from metastatic disease. F-18 FDG PET/CT can provide valuable information in finding the primary focus and metastases. Conflict of interest:None declared. Galenos Publishing 2012-04 2012-04-01 /pmc/articles/PMC3590961/ /pubmed/23487501 http://dx.doi.org/10.4274/Mirt.022866 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Abdulrezzak, Ummuhan
Tutus, Ahmet
Kula, Mustafa
Öztürk, Figen
Soyuer, Işın
Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
title Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
title_full Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
title_fullStr Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
title_full_unstemmed Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
title_short Is Every Patient Followed up as a Papillary Thyroid Cancer Patient Really That?
title_sort is every patient followed up as a papillary thyroid cancer patient really that?
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590961/
https://www.ncbi.nlm.nih.gov/pubmed/23487501
http://dx.doi.org/10.4274/Mirt.022866
work_keys_str_mv AT abdulrezzakummuhan iseverypatientfollowedupasapapillarythyroidcancerpatientreallythat
AT tutusahmet iseverypatientfollowedupasapapillarythyroidcancerpatientreallythat
AT kulamustafa iseverypatientfollowedupasapapillarythyroidcancerpatientreallythat
AT ozturkfigen iseverypatientfollowedupasapapillarythyroidcancerpatientreallythat
AT soyuerisın iseverypatientfollowedupasapapillarythyroidcancerpatientreallythat